Bio CEO & Investor Conference

February 10 - February 11, 2020

BIO CEO & Investor Conference
February 10-11, 2020, New York City
Register at:  https://www.bio.org/sites/default/files/CEO%202020%20Pre-Event%20Planner.pdf
Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Experience the best of biotech with two-days of productive partnering meetings with institutional investors, industry analysts, and senior biotechnology executives, in one location.
The aim of the Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies, a select group of late-stage private companies, and investors to foster the development of important new medicines that will expand the industry’s pipeline. All presentations are 13 minutes in length.
Companies interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics or platform technologies. Service providers will not be considered. Please note, there are registration and presentation fees associated with presenting.

Monday, February 10

6:00 AM – 6:00 PM 

Registration

6:30 AM – 8:00 AM

Continental Breakfast

6:30 AM – 6:00 PM

BIO One-on-One Partnering Desk

7:30 AM - 6:00 PM

BIO One-on-One Partnering Meetings

9:00 AM - 11:30 AM

Company Presentations

9:00 AM - 5:45 PM

Fireside Chats and Panel Sessions

11:15 AM - 5:55 PM

Company Presentations

6:00 PM – 7:00 PM

BIO CEO & Investor Conference Welcome Reception

 

Tuesday, February 11

6:30 AM - 4:00 PM

Registration

6:30 AM - 8:00 AM

Continental Breakfast

6:30 AM – 5:30 PM

BIO One-on-One Partnering Desk

7:00 AM – 5:30 PM

BIO One-on-One Partnering Meetings

9:00 AM - 11:30 AM

Company Presentations

9:00 AM - 5:00 PM

Fireside Chats and Panel Sessions

1:15 PM - 4:25 PM

Company Presentations

5:00 PM - 6:00 PM

BIO CEO & Investor Closing Reception

All final qualifications are determined by BIO.
The website notes this is one of the largest investor conferences "focused on established and emerging publicly traded and select biotech companies."
2019 Stats - this does not note how many attendees were investors:
630 delegates from 29 countries
2936 one-on-one meetings
290 companies represented
50 innovative companies presented


Learn More » View All Events »